RasmussenBKJensenRSchrollMOlesenJEpidemiology of headache in a general population a prevalence study.J Clin Epidemiol1991;
44:
1147–57
2.
RasmussenBKJensenROlesenJImpact of headache on sickness absence and utilization of medical services: a Danish population study.J Epidemiol Commun Health1992;
46:
443–6
3.
IslerHHistorical background to the headaches. In:
OlesenJPfelt-HansenPWelchKMA, editors.
The headaches.
New York:
Raven Press,1993:
18
4.
GrahamJRWolffHGMechanisms of migraine headache and action of ergotamine tartrate.Arch Neurol Psychiatr1938;
39:
737–63
5.
WolffHGHeadache and other head pain.
New York:
Oxford University Press,1963
6.
IversenHKNielsenTHOlesenJTfelt-HansenPArterial responses during migraine headache.Lancet1990;
336:
837–9
7.
BlauJNDexterSLThe site of pain origin during migraine attacks.Cephalalgia1981;
1:
143–7
8.
DrummondPDLanceJWExtracranial vascular changes and source of pain in migraine headache.Ann Neurol1983;
13:
32–7
9.
OlesenJTfelt-HansenPHenriksenLLarsenBThe common migraine attack may not be initiated by cerebral ischemia.Lancet1981;
2:
438–40
10.
AndersenARFribergLOlsenTSOlesenJDelayed hyperemia following hypoperfusion in classical migraine.Arch Neurol1988;
45:
154–9
11.
OlesenJCerebral and extracranial circulatory disturbances in migraine: pathophysiological implications.Cerebrovasc Brain Metab Rev1991;
3:
1–28
12.
DaugaardDThomsenLLOlesenJQuekenstedt's manoeuver in migraine. An evaluation of the importance of the venous system for migraine pain.
Cephalalgia1995:
15Suppl 14:
73
13.
FribergLOlesenJIversenHKSperlingBMigraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan.Lancet1991;
338:
13–17
14.
FurchgottRFZawadzkiJVThe obligatory role of endothelial cells in the relaxation of arterial smooth muscle, by acetylcholine.Nature1980;
288:
373–6
15.
PalmerRMJFerrigeAGMoncadaSNitric oxide release accounts for the biological activity of endothelium derived relaxing factor.Nature1987;
327:
524–6
IversenHKOlesenJTfelt-HansenPIntravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics.
Pain1989538:
1724
19.
IversenHKNielsenTHGarreKTfelt-HansenPOlesenJDose-dependent headache response and dilatation of extremity and extracranial arteries after three doses of 5-isosorbi-mononitrate.Fur J Clin Pharmacol1992;
42:
31–5
20.
MoncadaSPalmerRMJHiggsEANitric oxide: physiology, pathophysiology and pharmacology.
Pharmacol Rev1991;
43:
10941
21.
RandMJNitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuroeffector transmission.Clin Exp Pharmacol Physiol1992;
19:
147–69
22.
NozakiKMoskowitzMAMaynardKlKoketsuNDawsonTMBredtDSPossible origins and distribution of immunoactive nitric oxide synthetase-containing nerve fibers in cerebral arteries.
J Cereb Blood Flow Metab1993;
13:
709
23.
WeiEPMoskowitzMABaccaliniPKontosHACalcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside induced vasodilation in feline cerebral arterioles.Circ Res1992;
70:
1313–9
24.
MellerSTGebhartGFNitric oxide (NO) and nociceptive processing in the spinal cord.Pain1993;
52:
127–36
25.
LüscherTFVanhouttePMThe endothelium: modulator of cardiovascular functions.
Ann Arbor, Boston:
CRC Press,1990
26.
HibbsJBTaintorRRVavrinZRachlinEMNitric oxide: a cytotoxic activated macrophage effector molecule.Biochem Biophys Res Commun1988;
157:
87–94
27.
SalveminiDMasiniEPistelliAMannaioniPFVaneJRNitric oxide: a regulatory mediator of mast cell reactivity.J Cardiovasc Pharmacol1991;
17Suppl 3:
S258–64
28.
DawsonTMDawsonVLSnyderSHA novel neuronal messenger molecule in brain: the free radical, nitric oxide.Ann Neurol1992;
32:
297–311
29.
StamlerJSSingleDJLoscalzoJBiochemistry of nitric oxide and its redox-activated forms.Science1992;
258:
1898–902
WennmalmAPetersonAAnalysis of nitrite as a marker for endothelium derived relaxing factor in biological fluids using electron paramagnetic resonance spectrometry.J Cardiovasc Pharmacol1991;
17:
s34–40
32.
KelmMFeelischGrubeRMotzWStrauerBEMetabolism of endothelium-derived nitric oxide in human blood. In:
MoncadaSMarlettaMAHibbsJBHiggsEA, editors.
The biology of nitric oxide,
vol. 1.
London:
Portland Press,1992:
31922
33.
DoyleMPHoekstraJWOxidation of nitrogen oxides by bound dioxygen in hemoproteins.J Inorg Biochem1981;
14:
351–8
34.
ReifDWSimmonsRDNitric oxide mediates iron release from ferritin.Arch Biochem Biophys1990;
283:
537–41
35.
StamlerJSSimonDIOsborneJAMullinsMEJarakiOMichelTS-nitrosylation of proteins with nitric oxide—synthesis and characterization of biologically active compounds.Proc Natl Acad Sci USA1992;
89:
444–8
36.
VenturiniCMPalmerRMJMoncadaSVascular smooth muscle contains a depletable store of a vasodilator which is light-activated and restored by donors of nitric oxide.J Pharmacol Exp Ther1993;
266:
1497–500
37.
GryglewskiRJPalmerRMJMoncadaSSuperoxide anion is involved in the breakdown of endothelium-derived relaxing factor.Nature1986;
320:
454–6
38.
MayerBRegulation of nitric oxide synthase and soluble guanylyl cyclase.Cell Biochem Funct1994;
12:
167–77
39.
SchmidtKKlattPMayerBCharacterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.Mol Pharmaco1993;
44:
615–21
40.
GreeneBPacittiAJSoubaWWCharacterization of L-arginine transport by pulmonary artery endothelial cells.Am J Physiol1993;
264:
L351–6
41.
HeckerMSessaWCHarrisHJAnggardEEVareJRThe metabolism of L-arginine and its significance for the bio-synthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.Proc Natl Acad Sci USA1990;
87:
8612–6
42.
KnowlesRGMoncadaSNitric oxide synthases in mammals.Biochem J1994;
298:
249–58
43.
BusseRMlschAInduction of nitric oxide synthase by cytokines in vascular smooth muscle cells.FEBS Lett1990;
273:
87–90
44.
StuehrDJChoHJKwonNSWeiseMFNathanCFPurification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and PMN-containing flavoprotein.Proc Natl Acad Sci USA1991;
88:
7773–7
KishimotoJSpurtNLiaoMLizhiLEmsonXuWLocalization of brain nitric oxide synthase (NOS) to human chromosome 12.Genomics1992;
14:
802–4
47.
XuWGormanPSheerDBatesGKishimotoLLiuLEmsonPRegional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q24.-24.21 by fluorescent in situ hybridization.
Cytogene Cell Genet1993;
64:
623
48.
XuWCharlesIGMoncadaSGormanPSheerDLiuLEmsonPMapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively.Genomics1994;
21:
419–22
49.
TodaNMechanism underlying responses to histamine of isolated monkey and human cerebral arteries.Am Physiol1990;
258:
H311–7
50.
GarthwaiteJGlutamate, nitric oxide and cell-cell signalling in the nervous system.Trends Neurosci1991;
14:
60–7
51.
NamakiAHirataYIschikawaMMoroiMAikawaJMachiiKEndothelin-1 and endothelin-3 induced vasorelaxation via common generation of endothelium-derived nitric oxide.Life Sci1992;
50:
677–82
52.
GlusaERichterMEndothelium-dependent relaxation of porcine pulmonary arteries via 5HT1c-like receptors Naunyn SchmiedebergsArch Pharmacol1993;
347:
4717
53.
RubanyiGMRomeroJCVanhouttePMFlow induced release of endothelium-derived relaxing factor.Am Physiol1986;
250
(Heart and Circulatory Physiology 19):
H145–9
54.
CookeJPStamlerJAndonNDaviesPFMcKinnleyGLoscalzoJFlow stimulates endothelial cells tn release a nitrovasodilator that is potentiated by reduced thiol.
Am J Physiol1990:
259
(Heart and Circulatory Physiology 28), H804-12
55.
BugaGMGoldEFukutoJMIgnarroLJShear stress induced release of nitric oxide from endothelial cells grown on heads.Hypertension1991;
17:
187–93
RogersNEIgnarroLJConstitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine.Biochem Biophys Res Commun1992;
189:
242–9
58.
AssreuyJCunhaFQLiewFYMoncadaSfeedback? inhibition of nitric oxide synthase activity by nitric oxide.Br J Pharmacol1993;
108:
833–7
59.
BuxtonILOCheekDJEckmanDWestfallDPSandersKMKeelKDNG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.Circ Res1993;
72:
387–95
60.
BogleRGMoncadaSPearsonJDMannGEIdentification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.Br J Pharmacol1992;
105:
768–70
61.
HeckerMMitchellJAHarrisHJKatsuraMThiemermannCVaneJREndothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
Biochem Biophys Res Commun1990b;
167:
103743
62.
ArcherSLHamplVNG-monometyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise.Biochem Biophys Res Commun1992;
188:
590–6
63.
PetersonDAPetersonDCArcherSWeirEKThe non specificity of specific nitric oxide synthase inhibitors.Biochem Biophys Res Commun1992;
187:
797–801
64.
MiskoTPMooreWMKastenTPNickolsGACorbettJATiltonRGSelective inhibition of the inducible nitric oxide synthase by aminoguanidine.
Eur J Pharmacol1993;
233:
11925
IgnarroLJAeberhardEEHendersonSANonsteroidal anti-inflammatory drugs (NSAIDs) prevent transcriptional expression of the inducible NO synthase gene in macrophages by interference with NF-kB activation.Endothelium1995;
3
Suppl:
s2
(Abstract 8)
67.
MoorePKWallacePGaffenZHartSLBabbedgeRCCharacterization of the novel nitric oxide inhibitor 7-nitro-indazole and related indazolesantinociceptive and cardio-vascular effects.Br J Pharmacol1993;
110:
219–24
ZhuoMHuYHSchultzCKandelERHawkinsRDRole of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.Nature1994;
368:
635–9
70.
MarczinNRyanUSCatravasJDMethylene blue inhibits nitrovasodilator-and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.J Pharmacol Exp Ther1992;
263:
170–9
71.
MlschALckhoffPohlUBassengeELY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.Naunyn Schmiedebergs Arch Pharmacol1989;
340:
119–25
72.
BrandtMAConradKPIn vivo and in vitro studies of a putative inhibitor of cyclic guanosine 3',5'monophosphate production.Proc Soc Exp Biol Med1991;
196:
30–5
73.
LincolnTMCyclic GMP and mechanism of vasodilatation.Pharmacol Ther1989;
41:
479–502
74.
WalterUPhysiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system.Rev Physiol Biochem Pharmacol1989;
113:
41–88
75.
MarinJSanchez-FerrerCFRole of endothelium-formed nitric oxide on vascular responses.Gen Pharmacol1990;
21:
575–87
76.
GoyMFcGMP: the wayward child of the cyclic nucleotide family.Trends Neurosci1991;
14:
293–9
77.
ButtEGeigerJJarchauTLohmannSMWalterUThe cGMP-dependent protein kinase-gene, protein, and function.Neurochem Res1993;
18:
27–42
78.
SchmidtHHHWLohmannSMWalterUThe nitric oxide and cGMP signal transduction system—regulation and mechanisms of action.Biochim Biophys Acta1993;
1178:
153–75
79.
EcklyAELugnierCRole of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.Br J Pharmacol1994;
113:
445–50
80.
GrayDWMarshallINovel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vaso-relaxation in rat thoracic aorta.
Br J Pharmacol1992;
107:
68490
81.
GrayDWMarshallIHuman alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.
Br J Pharmacol1992;
107:
6916
82.
NathanCNitric oxide as a secretory product ot mammalian cells.FASEB J1992;
6:
3051–64
83.
AxelssonKLWikbergJEAndersonRGRelationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle.Life Sci1979;
24:
1779–89
84.
FeelischMNoackEACorrelation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
Eur J Pharmacol1987;
139:
1930
85.
GruetterCAKadowitzPJIgnarroLJMethylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrate and amyl nitrate.Can J Physiol Pharmacol1981;
59:
150–6
86.
IgnarroLJEndothelium-derived nitric oxide: plnarmacology and relationship to the actions of organic nitrate esters.Pharmacol Res1989;
6:
651–9
87.
FeelischMBiotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators.
Eur Heart J1993;
14Suppl 1:
12332
88.
HarrisonDGBatesJNThe nitrovasodilators. New ideas about old drugs.Circulation1993;
87:
1461–7
89.
Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.Cephalalgia1988;
8Suppl 7:
1–96
90.
IversenHKThornsenLLNitroglycerin induced headache -an experimental headache model. In:
OlesenJMoskowitzMA, editors.
Experimental headache models in animal and man.
New York:
Raven Press,1995:
2518
91.
SchnitkerTMSchnitkerMAA clinical test for migraine.
JAMA1947;
135:
8990
92.
Dalsgaard-NielsenTMigraine diagnostics with special reference to pharmacological tests.Int Arch Allergy1935;
7:
312–22
93.
HansenHJDrewesVMThe nitroglycerin ointment test—a double-blind examination.Danish Med Bull1970;
17:
226–9
94.
BonusoSMaranoEDi StasioESorgeFBarbieriEUllucciEASource of pain and primitive dysfunction in migraine: an identical site.J Neurol Neurosurg Psychiatry1989;
52:
1351–4
95.
SicuteriFDel BentEPoggioniMBonazziAUnmasking latent dysnociception in healthy subjects.
Headache1987;
27:
1805
96.
OlesenJIversenHKThomsenLLNitric oxide super-sensitivity. A possible molecular mechanism of migraine pain.Neuroreport1993;
4:
1027–30
ThomsenLLIversenHKBrinckTAOlesenJArterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers.Cephalalgia1993;
13:
395–9
99.
D'AndreaGCananziARPeriniFAlecciFZamberlanIHasselmarkLWelchKMADecreased collagen-induced platelet aggregation and increased arginine levels in migraine: a possible link with the NO pathway.
Cephalalgia1994;
14:
3527
100.
ClarkDHoughHWolffHGExperimental studies on headache: observations on headache produced by histamine.Arch Neurol Psychiatry1936;
35:
1054–69
101.
NorthfieldDWCSome observations on headache.Brain1938;
61:
133–62
102.
SchumacherGAWolffHGExperimental studies on headache.Arch Neurol Psychiatry1941;
45:
199–213
103.
FujiwaraMUsuiHKurahashiKJinoHShirahasaHMekataFEndothelium dependent contraction produced by acetylcholine and relaxation produced by histamine in monkey basilar arteries.J Cardiovasc Pharmacol1992;
20:
114–16
104.
KrabbeAEOlesenJHeadache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms.Pain1980;
8:
253–9
105.
De MarinisMFelicianiMJaniriLCerboRAgnoliAIncreased reactivity to a met-enkephalin analogue in the control of autonomic responses in migraine patients.Clin Neuropharmacol1990;
13:
507–21
106.
LassenLHThomsenLLOlesenJHistamine induces migraine via the H1-receptor. Support for the NO-hypothesis of migraine.Neuroreport1995;
6:
1475–9
107.
RoznieckiJJKuzminskaBPrusinskiAThe possible mechanism of nitroglycerin induced cluster headache attack. A proposal explanation.Cephalalgia1989;
9Suppl 10:
80–1
108.
IversenHKOlesenJNitroglycerin-induced headache is not dependent on histamine release. Support for a direct nociceptive action of nitric oxide.Cephalalgia1994;
14:
437–3
109.
LassenLHThomsenLLKruuseCIversenHKOlesenJH1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine.Eur J Clin Pharmacol1996;
49:
335–40
110.
OlesenJThomsenLLIversenHKNitric oxide is a key molecule in migraine and other vascular headaches.Trends Pharmacol Sci1994;
15:
149–53
111.
ThomsenLL.IversenHKLassenLHOlesenJThe role of nitric oxide in migraine pain: therapeutic implications.CNS Drugs1994;
2:
417–22
112.
FozardJRKalkmanHO5-Hydroxytryptamine (5HT) and the initiation of migraine: new perspectives.Naunyn Schmiedebergs Arch Pharmacol1994;
350:
225–9
113.
BrewertonTDMurphyDLMuellerEAJimersonDCInduction of migraine like headaches by the serotonin agonist m-chlorophenylpiperazine.
Clin Pharmacol Ther1988;
43:
6059
114.
GordonMLLiptonRBBrownSNakraseiveCRussellMPollackSZHeadache and cortisol responses to m-chlorophenylpiperazine are highly correlated.Cephalalgia1993;
13:
400–5
115.
OldendorfWHBrain uptake of radiolabeled aminoacids, amines and hexoses after arterial injection.Am J Physiol1971;
221:
1629–39
116.
LeoneAMFurstVWCelleckSWiklundNPMoncadaSVisualizing the cellular release of nitric oxide.
Endothelium1995:
3Suppl s5
(Abstract 19)
117.
OttossonALPJansenIEdvinssonLCharacterization of histamine receptors in isolated human cerebral arteries.Br J Pharmacol1988;
94:
901–7
118.
OttossonALPJansenIEdvinssonLPharmacological characterization of histamine receptors in the human temporal artery.Br J Clin Pharmacol1989;
27:
139–45
119.
OttossonALPJansenILangemarkMOlesenJEdvinssonLHistamine receptors in the isolated human middle meningeal artery. A comparison with cerebral and temporal arteries.Cephalalgia1991;
11:
183–8
120.
RayBSWolffHGExperimental studies on headache. Pain sensitive structures of the head and their significance in headache.Arch Surg1940;
41:
813–56
121.
NicholsFTIIIMawadMMohrJPSteinBHilalSMichelsenJFocal headache during balloon inflation in the internal carotid and middle cerebral arteries.Stroke1990;
21:
555–9
122.
AaslidRMarkwalderTMNornesHNon-invasive trans-cranial Doppler ultrasound recording of flow velocity in basal cerebral arteries.J Neurosurg1982;
57:
769–74
123.
NewellDWAaslidR, editors,
Transcranial Doppler.
New York:
Raven Press,1992
124.
ThomsenLLTranscranial Doppler examinations in relation to migraine pain.
PhD thesis University of Copenhagen. Private Press
1995:
171
125.
EvansDHMacphersonDSSome aspects of the relationship between instantaneous volumetric blood flow and continuous wave Doppler ultrasound recordings. II. A comparison between mean and maximum velocity waveforms in a canine model.Ultrasound Med Biol1982;
8:
611–15
126.
BusijaDWHeistadDDMarcusMLContinuous measurements of cerebral blood flow in anesthetized cats and dogs.Am J Physiol1981;
241:
H228–34
127.
AaslidRNornesHMusical murmurs in humar cerebral arteries after subarachnoid hemorrhage.J Neurosurg1984;
60:
32–6
128.
DahlARussellDNyberg-HansenRRootwellKEffect of nitroglycerin on cerebral circulation measured by transcranialDoppler and SPECT Stroke1989;
20:
17336
129.
IversenHKHolmSFribergLIntracranial hemodynamics during intravenous nitroglycerin infusion.Cephalalgia1989;
9Suppl 10:
84–5
130.
ThomsenLLIversenHKExperimental and biological variation of three-dimensional transcranial Doppler measurements.J Appl Physiol1993;
75:
2805–10
131.
HumphreyPPAGoadsbyPJThe mode of action of sumatriptan is vascular? A debate.Cephalalgia1994;
14:
401–10
132.
ThomsenLL,
Arterial mechanisms in the pathophysiology of migraine—therapeutic implications.
Eur J Neurol1995;
2:
40315
133.
ThomsenLLIversenHKOlesenJCerebral blood flow velocities are reduced during attacks of unilateral migraine without aura.Cephalalgia1995;
15:
109–16
134.
GulliksenGEnevoldsenEProlonged changes in rCBF following attacks of migraine accompagnée.Acta Neurol Scand1984;
69Suppl 98:
270–1
135.
LagrezeHLDettmersCHartmannAAbnormalities of interictal cerebral perfusion in classical but not common migraine.Stroke1988;
19:
1108–11
136.
LauritzenMOlesenJRegional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography.Brain1984;
107:
447–61
137.
FerrariMDHaanJBloklandKArndtJWMianeePZwindermanAHCerebral blood flow during migraine attacks without aura and effect of sumatriptan.Arch Neurol1995;
52:
135–9
138.
ZwetslootCPCaekebekeJFVFerrariMDLack of asymmetry of middle cerebral artery blood velocity in unilateral migraine.Stroke1993;
24:
1335–8
139.
ZanetteEMAgnoliARobertiCChiarottiFCirboRFieschiCTranscranial Doppler in spontaneous attacks of migraine.Stroke1992;
23:
680–5
140.
Pavy Le TraonACesariJBFabreNMoralesMPGeraudGBesAContribution of transcranial Doppler to the study of cerebral circulation in the migraineur. In:
Clifford RoseF, editor.
New advances in headache research.
London:
Smith-Gordon,1989:
15761
141.
ThieAFuhlendorfASpitzerKKunzeKTranscranial Doppler evaluation of common and classic migraine. Part II, Ultrasonic features during attacks.Headache1990;
30:
209–15
142.
DienerHCPetersCRudzioMNoeADirchgansHauxREhrmannRTfelt-HansenPErgotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraineurs.J Neurol1991;
238:
245–50
143.
ThomsenLLAhlgrenMIversenHKOlesenJMiddle cerebral artery blood velocity increase during experimental pressure pain in the head. In:
OlesenJMoskowitMA, editors.
Experimental headache models in animal and man.
New York:
Raven Press,1995:
3379
144.
ZanetteEMAgnoliACerboRChiarottiFRobertiCBuzziGFieschiCTranscranial Doppler (TCD after nitroglycerin in migraine without aura.Headache1991;
31:
596–8
145.
KrabbeAEOlesenJEffects of histamine on cerebral blood flow in man.Cephalalgia1982;
20:
15–18
146.
LassenLHThomsenLLOlesenJHistamine induces both immediate and delayed headache in migraineurs due to H1-receptor activation. Support for the NO hypothesis of migraine. In:
OlesenJMoskowitzMA, editors.
Abstracts of the 5th International Headache Research Seminar.
Copenhagen:
Notex Press,1994:
69
147.
ShekarYCAnandISSarmaRFerrariRWahiPLPoole-WilsonPAEffect of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal bloodflow and hormone levels in congestive heart failure.Am J Cardiol1991;
67:
732–6
148.
OlesenJPaulsonOBThe effect of intra-arterial papaverin on the regional cerebral blood flow in patients with stroke or intracranial tumors.Stroke1971;
2:
148–59
149.
YanagisawaMKuriharaHKimuraSTomobeYKobayashiMMitsuiYA novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature1988;
332:
411–5
150.
EdvinssonLGoadsbyPJNeuropeptides in migraine and cluster headache.
Cephalalgia1994;
14:
3208
151.
MoskowitzMANeurogenic inflammation in the pathophysiology and treatment of migraine.Neurology1993;
43Suppl 3:
S16–20
152.
EdvinssonLFunctional role of perivascular peptides in the control of cerebral regulation.Trends Neurosci1985;
8:
126–31
153.
BraydenJEBevanJAThe autonomic innervation of the cephalic circulation. In:
OlesenJEdvissonL, editors.
Basic mechanisms of headache.
Amsterdam:
Elsevier,1988:
14555
154.
ViziESPresynaptic modulation of neurochemical transmission.Prog Neurobiol1979;
12:
181–290
155.
StarkeKRegulation of noradrenalin release by presynaptic receptor systems.Rev Physiol Biochem Pharmacol1987;
107:
73–146
156.
GreenbergSSPeevyKTanakaTPEndothelium-derived and intraneuronal nitric oxide-dependent inhibition of norepinephrine efflux from sympathetic nerves by bradykinin.Am J Hypertens1991;
4:
464–7
157.
YangZvon SegesserLBauerEStulzATurinaMLüscherTFDifferent activation of the endothelial L-arginine pathway and cyclooxygenase pathway in the human internal mammary artery and vein.Circ Res1991;
68:
52–60
158.
MoncadaSReesDDSchulzRPalmerRMJDevelopment and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.Proc Natl Acad Sci USA1991;
88:
2166–170
159.
AndersonEAMarkALFlow-mediated and reflex changes in large peripheral artery tone in humans.Circulation1989;
79:
93–100
160.
CelermajerDSSorensenKEGoochVMSpiegelhalterDJMillerOISullivanIDNon-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet1992;
340:
1111–5
161.
HayozDDrexlerHMünzelTHorningBZeiherAMJustHFlow-mediated arterial dilatation is abnormal in congestive heart failure.Circulation1993;
87Suppl VII:
VII92–6
162.
JoannidesRHaefeliWELinderLRichardVBakkaliEHThuillezCLüscherTFNitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.Circulation1995;
91:
1314–9
163.
ThomsenLLDaugaardDIversenHKOlesenJNormal radial artery dilatation during reactive hyperemia in migraine without aura.Endothelium1996;
4:
199–206
164.
InoueAYanagisawaMKimuraSKasuyaYMiyauchiTGotoKMasakiTThe human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three different genes.Proc Natl Acad Sci USA1989;
86:
2863–7
165.
AndoKHirataYSchiriMEmoriTMarumoFPresence of imunoreactive endothelin in human plasma.FEBS Lett1989;
245:
164–6
166.
ThomsenLLIversenHKEmmeluthCBitPVenous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects.Eur J Clin Pharmacol1995;
48:
139–42
167.
SaijomaaORisimakiAFyhrquistFAtrial natriuretic peptide, nitroglycerin and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.Biochem Biophys Res Commun1990;
173:
514–20
168.
BoulangerCLüscherTFRelease of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide.J Clin Invest1990;
85:
587–90
169.
FarkkilaMPaloJSaijonmaaOFyhrquistFRaised plasma endothelin during acute migraine attack.Cephalalgia1992;
12:
383–4
170.
GallaiVSarchielliPFirenzeCTrequattriniAPaciaroniMUsaiFPalumboREndothelin 1 in migraine and tension-type headache.Acta Neurol Scand1994;
89:
47–55
171.
De NucciGThomasRD'Orleans-JustePAntunesEWalderCWarnerTDVaneJRPressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor.Proc Natl Acad Sci USA1988;
85:
9797–800
172.
ThomsenLLOlesenJThe autonomic nervous system and the regulation of arterial tone in migraine.Clin Ant Res1995;
5:
243–50
173.
ThomsenLLIversenHKBoesenFOlesenJTranscranial Doppler and cardiovascular responses during cardiovascular autonomic tests in migraineurs during and outside of attacks.Brain1995;
118:
1319–27
174.
Havanka-KanniainenHTolonenUMyllylaWAutonomic dysfunction in adult migraineurs.Headache1986;
26:
425–30
175.
GotohFKomatsumotaSArakiNGomiSNoradrenergic nervous activity in migraine.Arch Neurol1984;
41:
951–5
176.
MicieliGTassorelliCMagriMSandriniGCavalliniANappiGVegetative imbalance in migraine: a dynamic TV pupillometric evaluation.Punct Neurol1989;
4:
105–11
177.
OkadaFMiyagishiTHonmaMMichioUPlasma cyclic nucleotide responses to methacholine and epinephrine in patients with migraine.Headache1984;
24:
26–9
178.
MarkowitzSSaitoKMoskowitzMANeurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater not brain.J Neurosci1987;
7:
4129–36
179.
BuzziMGMoskowitzMAThe antimigraine drug sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.Br J Pharmacol1990;
99:
202–6
180.
BuzziMGCarterWBShimizuTHeathHIIIMoskowitzMADihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion.Neuropharmacology1991;
30:
1193–200
181.
MoskowitzMAThe neurobiology of vascular head pain.Ann Neurol1984;
16:
157–68
182.
GoadsbyPJEdvinssonLEkmanRRelease of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.Ann Neurol1988;
23:
193–6
183.
GoadsbyPJEdvinssonLEkmanRVasoactive peptide release in the extracerebral circulation of humans during migraine headache.Ann Neurol1990;
28:
183–7
184.
GoadsbyPJEdvinssonLSumatriptan reverses the changes in calcitonin gene-related peptide seen in the headache phase of migraine.Cephalalgia1991;
11Suppl 11:
3–4
185.
FribergLOlesenJOlesenTSKarleAEkmanRFahrenkrugJAbsence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Cephalalgia1994;
14:
4754
186.
DienerHCSubstance-P antagonist RPR100893-201 is not effective in human migraine attacks. In:
OlesenJTfelt-HansenP, editors.
Abstracts of the 6th International Headache Research Seminar.
Copenhagen:
Notex Press1995:
63
187.
MayAGijsmanHJWallnöferAJonesRDienerHCFerrariMDEndothelin antagonist Bosentan blocks neurogenic inflammation but is not effective in aborting migraine attacks. In:
OlesenJTfelt-HansenP, editors.
Abstracts of the 6th International Headache Research Seminar.
Copenhagen:
Notex Press,1995:
69
188.
JansenIIversenHOlesenJEdvinssonLThe effect of nitoglycerin on sensory neuropeptides in isolated guinea pig basilar arteries:Cephalalgia1993;
13Suppl 13:
141
FanciullacciMAlassandrMFigniMGeppettiPMichelacciSIncrease in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.Pain1995;
60:
119–23
191.
McMahonSBLewinGRWallPDCentral hyperexcitability triggered by noxious inputs.Curr Opin Neurobiol1993;
3:
602–10
192.
ThomsenLLBrennumJIversenHKOlesenJEffect of a NO donor (glyceryl trinitrate) on nociceptive thresholds in man.Cephalalgia1996;
16:
169–74
193.
DavisKDDostrovskyJOResponses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus.
J Neurophysiol1988;
59:
64866
194.
SessleBJHuJWAmanoNZhongGConvergence of cutaneous, tooth pulp, viceral, neck and muscle afferents onto nociceptive and non-nociceptive neurons in trigeminal subnucleus caudalis (medullary dorsal horn) and its implications for referred pain.Pain1986;
27:
219–35
195.
MoskowitzMADrug mechanisms in acute migraine. In:
GebhartGFHammondDLJensenTS, editors.
Proceedings of the 7th World Congress on Pain.
Seattle:
IASP Press,1994:
75564
196.
MoussaouiSMLeeWSCutrerMBoniciCGarretCMoskowitzMARPR 100893, a novel non-peptide antagonist of the human NK 1 receptor: effect in two guinea-pig models of migraine; dural neurogenic inflammation and c-fos expression induced in the CNS by nociceptive stimulations. In:
Clifford RoseF, editor.
New advances in headache research,
vol 4.
London:
Smith Gordon,1994:
327
197.
LauritzenMPathophysiology of the migraine aura. The spreading depression theory.Brain1994;
117:
199–210
198.
ChoppMChenQZhangZGBodzinGWelchKMANitric oxide synthase is induced in cerebral endothelial cells by spreading depression.
Cephalalgia1993;
13Suppl 13:
117
199.
OlesenJThomsenLLLassenLHJansen OlesenIThe nitric oxide hypothesis of migraine and other vascular headaches.Cephalalgia1995;
15:
94–100
